Table 2.
Five-year-LRFS and 5-year OS in TNBC
| Prognostic factor | 5-year LRFS (%) |
P-value | 5-year OS (%) |
P-value |
|---|---|---|---|---|
| All patients | ||||
| TNBC (111 patients) | 88±6 | 0.8 | 54±8 | 0.04 |
| Non-TNBC (111 patients) | 90±11 | 72±10 | ||
| TNBC patients | ||||
| Radiation therapy | ||||
| PORT | 94±4 | 0.001 | 65±13 | 0.09 |
| Non-PORT | 82±7 | 51±6 | ||
| Surgical treatment | ||||
| MRM (67 patients) | 85±5 | 0.2 | 43±7 | 0.11 |
| BCT (44 patients) | 90±8 | 57±10 | ||
| Chemotherapy | ||||
| Neoadjuvant (51 patients) | 87±5 | 0.4 | 55±5 | 0.3 |
| Adjuvant (48 patients) | 86±6 | 58±4 | ||
Abbreviations: BCT, breast-conserving treatment; LRFS, local recurrence-free survival; MRM, modified radical mastectomy; OS, overall survival; PORT, postoperative radiotherapy; TNBC, triple-negative breast cancer.